JANSSEN PHARMS FDA Approval NDA 020634

NDA 020634

JANSSEN PHARMS

FDA Drug Application

Application #020634

Documents

Letter1998-12-17
Letter2000-02-02
Letter2000-02-02
Letter2000-09-08
Letter2001-12-18
Letter2003-06-08
Letter2003-12-04
Letter2004-09-15
Letter2004-12-02
Letter2004-11-08
Letter2007-06-04
Letter2007-05-16
Letter2007-07-05
Letter2007-11-19
Letter2007-11-19
Letter2008-01-09
Letter2009-05-05
Letter2011-03-03
Letter2011-10-13
Label2000-09-08
Label2001-12-18
Label2004-09-15
Label2007-09-19
Label2007-06-04
Label2007-09-19
Label2007-06-27
Label2007-11-19
Label2007-12-14
Label2008-06-05
Label2011-03-04
Label2011-10-12
Label2011-10-12
Label2013-08-15
Label2016-07-26
Review1999-07-02
Review2004-09-09
Review2005-06-27
Review2005-06-27
Review2008-08-01
Summary Review2008-07-16
Letter2000-09-08
Letter2001-12-18
Letter2001-12-18
Letter2002-10-30
Letter2004-03-10
Letter2004-09-15
Letter2005-08-08
Letter2006-06-28
Letter2007-09-25
Letter2007-09-25
Letter2008-05-08
Letter2008-04-18
Letter2008-10-07
Letter2009-03-13
Letter2011-06-14
Letter2012-05-01
Letter2011-10-13
Letter2013-08-16
Letter2014-05-28
Letter2016-07-26
Label2004-06-08
Label2000-09-08
Label2001-12-18
Label2001-12-18
Label2003-06-08
Label2004-04-05
Label2004-07-21
Label2004-09-15
Label2004-12-03
Label2004-11-08
Label2005-08-08
Label2006-01-27
Label2006-06-28
Label2007-05-16
Label2007-11-19
Label2008-10-08
Label2009-05-11
Label2011-06-14
Label2012-04-30
Label2014-05-28
Review2007-04-24
Review2004-09-09
Review2005-06-27
Review2008-08-01
Review2009-09-17
Review2009-09-17
Review2015-03-11
Review2012-06-22
Review2012-06-22
Other2004-06-08
Letter2017-02-09
Label2017-02-10
Pediatric Written Request1900-01-01
Pediatric Amendment 11900-01-01
Pediatric Clinical Pharmacology Review1900-01-01
Pediatric Statistical Review1900-01-01
Pediatric Medical Review1900-01-01
Label2018-07-03
Medication Guide2018-07-03
Letter2018-07-06
Label2018-10-19
Medication Guide2018-10-19
Letter2018-10-23
Letter2019-05-06
Label2019-05-08
Letter2019-07-01
Label2019-07-02
Medication Guide2019-07-02
Letter2020-06-24
Label2020-07-02
Medication Guide2020-07-02

Application Sponsors

NDA 020634JANSSEN PHARMS

Marketing Status

Discontinued001
Discontinued002
Discontinued003

Application Products

001TABLET;ORAL250MG1LEVAQUINLEVOFLOXACIN
002TABLET;ORAL500MG1LEVAQUINLEVOFLOXACIN
003TABLET;ORAL750MG1LEVAQUINLEVOFLOXACIN

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP1996-12-20N/A
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1998-05-11STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1998-03-24STANDARD
EFFICACY; EfficacySUPPL4AP1998-12-17STANDARD
LABELING; LabelingSUPPL5AP1999-07-29STANDARD
LABELING; LabelingSUPPL6AP1999-07-29STANDARD
LABELING; LabelingSUPPL7AP1999-07-29STANDARD
EFFICACY; EfficacySUPPL8AP2000-02-02STANDARD
LABELING; LabelingSUPPL9AP2000-02-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1999-09-29STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL11AP2000-02-11STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL12AP2000-09-08STANDARD
EFFICACY; EfficacySUPPL13AP2000-09-08STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL14AP2000-08-28STANDARD
LABELING; LabelingSUPPL15AP2001-12-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL16AP2000-12-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL17AP2000-09-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL18AP2001-01-04STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL19AP2001-02-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL20AP2001-06-08STANDARD
LABELING; LabelingSUPPL21AP2001-12-18STANDARD
LABELING; LabelingSUPPL22AP2001-12-18STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL23AP2002-01-11STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL24AP2002-04-30STANDARD
EFFICACY; EfficacySUPPL25AP2002-10-30PRIORITY
MANUF (CMC); Manufacturing (CMC)SUPPL26AP2002-06-12STANDARD
EFFICACY; EfficacySUPPL27AP2003-05-23STANDARD
EFFICACY; EfficacySUPPL28AP2003-10-23STANDARD
LABELING; LabelingSUPPL29AP2004-03-05STANDARD
EFFICACY; EfficacySUPPL30AP2004-07-14PRIORITY
LABELING; LabelingSUPPL33AP2004-09-14STANDARD
LABELING; LabelingSUPPL34AP2004-09-14STANDARD
EFFICACY; EfficacySUPPL35AP2004-11-24PRIORITY
LABELING; LabelingSUPPL36AP2004-11-04STANDARD
EFFICACY; EfficacySUPPL37AP2005-08-04UNKNOWN
LABELING; LabelingSUPPL39AP2006-01-20STANDARD
LABELING; LabelingSUPPL40AP2006-06-23STANDARD
EFFICACY; EfficacySUPPL41AP2007-09-14UNKNOWN
LABELING; LabelingSUPPL42AP2007-05-31STANDARD
EFFICACY; EfficacySUPPL43AP2007-09-11PRIORITY
LABELING; LabelingSUPPL44AP2007-05-10STANDARD
LABELING; LabelingSUPPL45AP2007-06-19STANDARD
EFFICACY; EfficacySUPPL47AP2008-05-05UNKNOWN
LABELING; LabelingSUPPL48AP2007-11-15STANDARD
LABELING; LabelingSUPPL49AP2007-11-16STANDARD
LABELING; LabelingSUPPL50AP2007-12-13STANDARD
LABELING; LabelingSUPPL51AP2008-04-16STANDARD
LABELING; LabelingSUPPL52AP2008-10-03STANDARD
LABELING; LabelingSUPPL53AP2009-04-27STANDARD
LABELING; LabelingSUPPL54AP2009-03-12STANDARD
LABELING; LabelingSUPPL58AP2011-02-25901 REQUIRED
LABELING; LabelingSUPPL59AP2011-06-09UNKNOWN
EFFICACY; EfficacySUPPL61AP2012-04-27PRIORITY
LABELING; LabelingSUPPL62AP2011-10-11UNKNOWN
REMS; REMSSUPPL64AP2011-10-11N/A
LABELING; LabelingSUPPL65AP2013-08-14901 REQUIRED
LABELING; LabelingSUPPL66AP2014-05-23STANDARD
LABELING; LabelingSUPPL67AP2016-07-26STANDARD
LABELING; LabelingSUPPL68AP2017-02-08STANDARD Please see www.fda.gov/STIC for labeling requirements on susceptibility test interpretive criteria for systemic antibacterial and antifungal drugs.
LABELING; LabelingSUPPL69AP2018-07-02STANDARD
LABELING; LabelingSUPPL70AP2018-10-18STANDARD
LABELING; LabelingSUPPL71AP2019-06-28STANDARD
LABELING; LabelingSUPPL72AP2019-05-03STANDARD
LABELING; LabelingSUPPL73AP2020-06-22STANDARD

Submissions Property Types

ORIG1Null10
SUPPL2Null0
SUPPL3Null0
SUPPL10Null0
SUPPL11Null0
SUPPL12Null0
SUPPL14Null0
SUPPL16Null0
SUPPL17Null0
SUPPL18Null0
SUPPL19Null0
SUPPL20Null0
SUPPL23Null0
SUPPL24Null0
SUPPL26Null0
SUPPL35Null41
SUPPL43Null26
SUPPL53Null7
SUPPL58Null6
SUPPL59Null6
SUPPL61Null21
SUPPL62Null6
SUPPL64Null6
SUPPL65Null6
SUPPL66Null6
SUPPL67Null7
SUPPL68Null7
SUPPL69Null15
SUPPL70Null15
SUPPL71Null6
SUPPL72Null7
SUPPL73Null7

CDER Filings

JANSSEN PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 20634
            [companyName] => JANSSEN PHARMS
            [docInserts] => ["Medication Guide","https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/020634s073lbl.pdf#page=54"]
            [products] => [{"drugName":"LEVAQUIN","activeIngredients":"LEVOFLOXACIN","strength":"250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"LEVAQUIN","activeIngredients":"LEVOFLOXACIN","strength":"500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"},{"drugName":"LEVAQUIN","activeIngredients":"LEVOFLOXACIN","strength":"750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"06\/22\/2020","submission":"SUPPL-73","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/020634s073lbl.pdf\"}]","notes":""},{"actionDate":"06\/28\/2019","submission":"SUPPL-71","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/020634s071lbl.pdf\"}]","notes":""},{"actionDate":"05\/03\/2019","submission":"SUPPL-72","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/020634s072lbl.pdf\"}]","notes":""},{"actionDate":"10\/18\/2018","submission":"SUPPL-70","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/020634s070lbl.pdf\"}]","notes":""},{"actionDate":"07\/02\/2018","submission":"SUPPL-69","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/020634s069lbl.pdf\"}]","notes":""},{"actionDate":"02\/08\/2017","submission":"SUPPL-68","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2017\\\/020634s068,020635s074,021721s035lbl.pdf\"}]","notes":"Please see"},{"actionDate":"07\/26\/2016","submission":"SUPPL-67","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/020634s067,020635s073,021721s034lbl.pdf\"}]","notes":""},{"actionDate":"05\/23\/2014","submission":"SUPPL-66","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2014\\\/020634s066,020635s072,021721s033lbl.pdf\"}]","notes":""},{"actionDate":"08\/14\/2013","submission":"SUPPL-65","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2013\\\/020634s065,020635s071,021721s032lbl.pdf\"}]","notes":""},{"actionDate":"04\/27\/2012","submission":"SUPPL-61","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/020634s061,020635s067,021721s028lbl.pdf\"}]","notes":""},{"actionDate":"10\/11\/2011","submission":"SUPPL-64","supplementCategories":"REMS-Modified","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/020634s062s064,020635s068s070,021721s029s031lbl.pdf\"}]","notes":""},{"actionDate":"10\/11\/2011","submission":"SUPPL-62","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/020634s062s064,020635s068s070,021721s029s031lbl.pdf\"}]","notes":""},{"actionDate":"10\/11\/2011","submission":"SUPPL-62","supplementCategories":"Labeling-Medication Guide","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/020634s062s064,020635s068s070,021721s029s031lbl.pdf\"}]","notes":""},{"actionDate":"06\/09\/2011","submission":"SUPPL-59","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/020634s059,020635s065,021721s026lbl.pdf\"}]","notes":""},{"actionDate":"02\/25\/2011","submission":"SUPPL-58","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2011\\\/020634s058,020635s064,021721s025lbl.pdf\"}]","notes":""},{"actionDate":"04\/27\/2009","submission":"SUPPL-53","supplementCategories":"REMS-Proposal","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""},{"actionDate":"04\/27\/2009","submission":"SUPPL-53","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"\"}]","notes":""},{"actionDate":"10\/03\/2008","submission":"SUPPL-52","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/021721s020_020635s57_020634s52_lbl.pdf\"}]","notes":""},{"actionDate":"04\/16\/2008","submission":"SUPPL-51","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/020634s051,020635s055,021721s019lbl.pdf\"}]","notes":""},{"actionDate":"12\/13\/2007","submission":"SUPPL-50","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/020634s050,020635s054,021721s018lbl.pdf\"}]","notes":""},{"actionDate":"11\/16\/2007","submission":"SUPPL-49","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/020634s049,020635s053,021721s017lbl.pdf\"}]","notes":""},{"actionDate":"11\/15\/2007","submission":"SUPPL-48","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/020634s048,020635s052,021721s016lbl.pdf\"}]","notes":""},{"actionDate":"09\/14\/2007","submission":"SUPPL-41","supplementCategories":"Efficacy-New Dosing Regimen","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/020634s041,020635s044,021721s009lbl.pdf\"}]","notes":""},{"actionDate":"09\/11\/2007","submission":"SUPPL-43","supplementCategories":"Efficacy-New Patient Population","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/020634s043,020635s046,021721s011lbl.pdf\"}]","notes":""},{"actionDate":"06\/19\/2007","submission":"SUPPL-45","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/020634s045,020635s048,021721s031lbl.pdf\"}]","notes":""},{"actionDate":"05\/31\/2007","submission":"SUPPL-42","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/020634s042,020635s045,021721s010lbl.pdf\"}]","notes":""},{"actionDate":"05\/10\/2007","submission":"SUPPL-44","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/020634s044,020635s047,021721s012lbl.pdf\"}]","notes":""},{"actionDate":"06\/23\/2006","submission":"SUPPL-40","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020634s040,020635s043,021721s007lbl.pdf\"}]","notes":""},{"actionDate":"01\/20\/2006","submission":"SUPPL-39","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2006\\\/020634s039,020635s042,021721s006lbl.pdf\"}]","notes":""},{"actionDate":"08\/04\/2005","submission":"SUPPL-37","supplementCategories":"Efficacy-New Dosing Regimen","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2005\\\/020634s037,020635s038,021721s002lbl.pdf\"}]","notes":""},{"actionDate":"11\/24\/2004","submission":"SUPPL-35","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/20634s035,20635s035,21721s003lbl.pdf\"}]","notes":""},{"actionDate":"11\/04\/2004","submission":"SUPPL-36","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/20635s037,20634s036lbl.pdf\"}]","notes":""},{"actionDate":"09\/14\/2004","submission":"SUPPL-34","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/20634s033,034,20635s033,034lbl.pdf\"}]","notes":""},{"actionDate":"09\/14\/2004","submission":"SUPPL-33","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/20634s033,034,20635s033,034lbl.pdf\"}]","notes":""},{"actionDate":"07\/14\/2004","submission":"SUPPL-30","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/20634s030,20635s030lbl.pdf\"}]","notes":""},{"actionDate":"03\/05\/2004","submission":"SUPPL-29","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2004\\\/20634slr029,20635slr029_levaquin_lbl.pdf\"}]","notes":""},{"actionDate":"05\/23\/2003","submission":"SUPPL-27","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2003\\\/20634se1-027,20635se1-026_levaquin_lbl.pdf\"}]","notes":""},{"actionDate":"12\/18\/2001","submission":"SUPPL-22","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/20634s15s21s22lbl.pdf\"}]","notes":""},{"actionDate":"12\/18\/2001","submission":"SUPPL-21","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/20634s15s21s22lbl.pdf\"}]","notes":""},{"actionDate":"12\/18\/2001","submission":"SUPPL-15","supplementCategories":"Labeling","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2001\\\/20634s15s21s22lbl.pdf\"}]","notes":""},{"actionDate":"09\/08\/2000","submission":"SUPPL-13","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2000\\\/20634S13lbl.pdf\"}]","notes":""},{"actionDate":"09\/08\/2000","submission":"SUPPL-12","supplementCategories":"Manufacturing (CMC)-Control","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2000\\\/20634S13lbl.pdf\"}]","notes":"This supplement type does not usually require new labeling."},{"actionDate":"12\/17\/1998","submission":"SUPPL-4","supplementCategories":"Efficacy-New Indication","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/nda\\\/98\\\/020634s04_prntlbl_P1.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"LEVAQUIN","submission":"LEVOFLOXACIN","actionType":"250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"LEVAQUIN","submission":"LEVOFLOXACIN","actionType":"500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"},{"actionDate":"LEVAQUIN","submission":"LEVOFLOXACIN","actionType":"750MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2020-06-22
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.